๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Seoul
Clinical trial register · South Korea

Clinical Trials in Seoul, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 3364 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:49 UTC
3364
Studies in scope
all four open statuses
1829
Recruiting now
open to new participants
503
Lead sponsors
across recruiting studies
Top sites
Seoul 2820 Daegu 550 Seongnam-si 485 Busan 464 Goyang-si 395
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca195 Seoul National University Hospital187 Yonsei University147 Samsung Medical Center142 Merck Sharp & Dohme LLC112
Site location
Seoul2820 Daegu550 Seongnam-si485 Busan464 Goyang-si395
All 252 locations
Target enrolment
to

Trials with a site in Seoul

2820 of 3364 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
NCT06995833Endometrial Cancer
AstraZeneca
Observational
50
Seoul
2025-09-19
Recruiting
Transcatheter Arterial Embolization Using Nexsphere-F for Chronic Shoulder Pain Refractory to Conservative Treatment
NCT07336849Adhesive Capsulitis of the Shoulder, Frozen Shoulder, Shoulder Adhesive Capsulitis
Chung-Ang University Hospital
Not applicable
44
Seoul
2025-09-18
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
NCT07190222Chronic Obstructive Pulmonary Disease
DrugLunsekimig
Sanofi
Phase 3
942
Anyang-si, Daegu, Jeonju, Seoul
2025-09-17
Recruiting
Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage โ…  Hypertension
NCT07515599Stage 1 Hypertension
Daewoong Pharmaceutical Co. LTD.
Observational
12,000
Seoul
2025-09-17
Active, closed
Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects
NCT07200986Healthy Participants
DrugIxekizumab
Celltrion
Phase 1
218
Busan, Seongnam-si, Cheongju-si, Seoul
2025-09-17
Not yet open
LTFU for All Cell and Gene Therapy Studies
NCT06194461Hepatocellular Carcinoma, Prostate Cancer
DrugsAZD0754·AZD5851
AstraZeneca
Observational
64
Seoul
2025-09-17
Recruiting
Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19
NCT07157007COVID - 19
DrugPaxlovid
Traws Pharma, Inc.
Phase 2
90
Gwangju, Seoul, Wลnju, Incheon
2025-09-16
Recruiting
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
NCT07037758Extensive Stage Small Cell Lung Cancer
DrugsEtakafusp alfa·Tarlatamab
Amgen
Phase 1
380
Cheongju Chungbuk, Seongnam-si, Gyeonggi-do, Seoul
2025-09-16
Recruiting
Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC
NCT07225374Upper Tract Urothelial Carcinoma
DrugAvelumab
Samsung Medical Center
Phase 2
48
Seoul
2025-09-16
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Seoul
2025-09-16
Recruiting
Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
NCT07695207Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
SANGMYUNG innovation
Phase 3
266
Seoul
2025-09-15
Recruiting
Dynamics of Dysbiosis in the Skin and Gut Microbiome of Burn Patients
NCT07209007Burn Injuries, Skin Disease, Microbiome, Microbiome Dysbiosis
Cho Yoon soo
Observational
600
Seoul
2025-09-15
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
400
Seongnam, Seoul
2025-09-13
Recruiting
Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy
NCT06920251Relapsed Refractory Multiple Myeloma (RRMM)
DrugsLetermovir·Elranatamab
Seoul National University Hospital
Phase 2
40
Seoul
2025-09-11
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
NCT06926868Breast Neoplasms
DrugsIza-bren·Nab-paclitaxel·Capecitabine·Gemcitabine
Bristol-Myers Squibb
Phase 2/3
600
Goyang-si, Seongnam, Seoul, Daegu
2025-09-11
Not yet open
Effects of Hip Blood Flow Restriction and Shockwave Therapy on Q-Angle and Plantar Pressure in Adults With Genu Varum
NCT07140796Genu Varum
Sungjin Park
Not applicable
14
Seoul
2025-09-10
Recruiting
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
NCT06919965Non-Muscle Invasive Bladder Neoplasms
DrugsErdafitinib·Mitomycin C·Gemcitabine
Janssen Research & Development, LLC
Phase 3
220
Cheongju-si, Gangnam Gu, Seongnam-si, Seoul
2025-09-10
Recruiting
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
NCT07054190Breast Cancer
DrugsGiredestrant·Inavolisib·Ribociclib·Letrozole
Hoffmann-La Roche
Phase 2
120
Seoul
2025-09-09
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT07011719Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Cabozantinib
Arcus Biosciences, Inc.
Phase 3
720
Busan, Daejeon, Goyang, Seongnam, Seoul, Suwon
2025-09-08
Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT06973187Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
DrugsTacabrutideg·Pirtobrutinib
BeOne Medicines
Phase 3
500
Seogu, Seongnam-si, Jinju, SeochoGu, SeodaemunGu, Seoul
2025-09-04
Recruiting
Low (-4) vs Physiologic (-8) Pressure Digital Continuous Suction After Lung Resection
NCT07527702Lung Cancer Patient
Seoul National University Hospital
Not applicable
160
Seoul
2025-09-03
Recruiting
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT07164443Metastatic Castration-resistant Prostatic Neoplasms
DrugsJNJ-87189401·Pasritamig
Janssen Research & Development, LLC
Phase 3
1,203
Daejeon, Goyang-si, Hwasungun, Seoul
2025-09-02
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
NCT07023289Colorectal Cancer
DrugTelisotuzumab Adizutecan
AbbVie
Phase 2
140
Seoul
2025-09-02
Recruiting
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
NCT07136467Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa
AbbVie
Observational
2,795
Seoul
2025-09-02
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Daegu, Gwangju, Namdong-gu, Seongnam, Seoul, Suwon, Ulsan
2025-09-02
Recruiting
Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients
NCT06893783Neuroendocrine Carcinomas (NEC), Neuroendocrine Carcinoma of Pancreas, Neuroendocrine Carcinoma of Prostate
DrugTarlatamab
Inkeun Park
Phase 2
60
Seoul
2025-09-02
Active, closed
A Clinical Trial to Evaluate the Effect of Grapefruit Juice on the PK/PD of Edoxaban
NCT07113054Healthy
DrugEdoxaban
Hyewon Chung
Phase 1
14
Seoul
2025-09-02
Not yet open
Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery
NCT06144112Liver Diseases
DrugsFresh frozen plasma·Prothrombin Complex
Konkuk University Medical Center
Phase 4
92
Seoul
2025-09-01
Recruiting
PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers
NCT07144176Healthy Subjects
Daewoong Pharmaceutical Co. LTD.
Phase 1
60
Seoul
2025-09
Not yet open
Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure
NCT07123506Atrial Fibrillation, Atrial Flutter, Tachycardia, Supraventricular, Heart Septal Defects, Atrial
Yonsei University
Not applicable
350
Seoul
2025-09
Not yet open
Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors
NCT07108985Diabetes Mellitus, Type 2, Hyperglycemia, Insulin Resistance
DrugsSitagliptin·Dapagliflozin
Yonsei University
Phase 4
100
Seoul
2025-09
Not yet open
The Effects of Stroboscopic Visual Conditions on Gait and Lower Limb Muscle Activity in Individuals With Chronic Ankle Instability
NCT07134829Chronic Ankle Instability
Sahmyook University
Not applicable
25
Seoul
2025-08-31
Recruiting
A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia
NCT07016269Biliary Dyspepsia
Myungmoon Pharma. Co. Ltd.
Phase 4
358
Ansan, Suwon, Busan, Gyeonggi-do, Incheon, Seoul
2025-08-29
Recruiting
COPM-Based Goal Setting Strategies in the PICU
NCT07128446Critical Illness, Pediatric Intensive Care Unit
Samsung Medical Center
Not applicable
5
Seoul
2025-08-29
Recruiting
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
NCT07128303Advanced Solid Tumor
DrugsPemetrexed·Carboplatin·Pembrolizumab
Gilead Sciences
Phase 1
476
Seoul
2025-08-28
Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
NCT06989359IgAN, C3G, Complement-mediated Kidney Disease, IgA Nephropathy (IgAN)
ADARx Pharmaceuticals, Inc.
Phase 2
45
Wลnju, Gyeonggi-do, Seoul, Cheonan, Daegu
2025-08-28
Recruiting
Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy Adults
NCT07161180Healthy Volunteers
Pharmbio Korea Co., Ltd.
Phase 1
32
Seoul
2025-08-27
Recruiting
mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Second-line
NCT07062536Biliary Cancer Metastatic
DrugMFOLFOX
Seoul National University Bundang Hospital
Phase 2
130
Busan, Daegu, Gangneung, Seongnam-si, Incheon, Hwasun, Cheongju-si, Seoul
2025-08-27
Recruiting
A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
NCT07152119Severe Alopecia Areata
DrugLitfulo
Pfizer
Observational
3,000
Seoul
2025-08-27
Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07043400Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
DrugsLeucovorin·Adrucil·Tislelizumab·Capecitabine
BeOne Medicines
Phase 3
351
Seongnam-si, BukGu, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2025-08-27
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
NCT06982521PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Breast Cancer
DrugsCapivasertib·Fulvestrant
Relay Therapeutics, Inc.
Phase 3
540
Seongnam-si, Seoul
2025-08-26
Recruiting
A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)
NCT07164833Ischemia Reperfusion Injury, Cardiac Surgery Associated - Acute Kidney Injury
Bilix Co.,Ltd.
Phase 2
50
Daegu, Seongnam, Seoul, Yangsan
2025-08-26
Recruiting
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
NCT07160244Healthy
Drug20-valent pneumococcal conjugate vaccine
Pfizer
Phase 3
6,000
Chuncheon, Gwangju, Seoul, Daegu
2025-08-25
Recruiting
An International Observational Study of Adults With Acute Infection
NCT07069400Infectious Disease
University of Minnesota
Observational
1,500
Seongnam-si, Seoul
2025-08-25
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
DrugsEmpasiprubart·IVIG
argenx
Phase 3
218
Busan, Seoul
2025-08-22
Recruiting
Effectiveness and Safety of Pharmacopuncture Therapy for Chronic Lumbar Radiculopathy: A Multicenter, Pragmatic, Randomized, Comparative Clinical Trial
NCT07832318Lumbar Radiculopathy, Chronic Pain
Jaseng Medical Foundation
Not applicable
92
Bucheon-si, Seongnam-si, Seoul
2025-08-22
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT06959524Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation
Not applicable
1,616
Seoul
2025-08-21
Active, closed
Real-world Immunogenicity of Anti-IL5/5a Antibody
NCT07567690Asthma, Immunogenicity, Biologics
Samsung Medical Center
Observational
100
Seoul
2025-08-19
Recruiting
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
NCT07005154Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
DrugsASP5541·Abiraterone acetate·Prednisolone·Prednisone
Astellas Pharma Global Development, Inc.
Phase 2
218
Daegu, Gwangju, Seoul
2025-08-19
Recruiting
Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
NCT06954714Coronary Artery Disease
Chonnam National University Hospital
Not applicable
256
Busan, Daegu, Gwangju, Jeonju, Seoul, Ulsan
2025-08-18
Active, closed
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
NCT07005128Small-cell Lung Cancer, Extensive Stage Small-cell Lung Cancer
DrugsTarlatamab·Etoposide·Durvalumab·Carboplatin
Amgen
Phase 3
350
Cheongju Chungbuk, Goyang-si Gyeonggi-do, Seoul
2025-08-18
Recruiting
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
NCT07196501Major Depressive Disorder
DrugNBI-1065845
Neurocrine Biosciences
Phase 3
550
Ansan-si, Seoul
2025-08-18
Not yet open
Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea
NCT06942156Heart Transplant
DrugsMycophenolate Mofetil·Everolimus
Chong Kun Dang Pharmaceutical
Phase 4
140
Seoul
2025-08-14
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06948318Immune Thrombocytopenic Purpura (ITP)
DrugMezagitamab
Takeda
Phase 3
150
Seongnam-si, Daegu, Seoul
2025-08-14
Recruiting
Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)
NCT06770543Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals
Observational
1,500
Yangsan, Busan, Seoul, Taegu
2025-08-13
By invitation
NEPA in Patients With HER2-positive or HER2-low Advanced Breast Cancer Treated With T-DXd
NCT07132749Patients With HER2-positive Advanced Breast Cancer Treated With T-DXd, Patients With HER2-low Advanced Breast Cancer Treated With T-DXd
Yeon Hee Park
Observational
100
Seoul
2025-08-12
Recruiting
A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Interaction and the Safety of UIC202502 and UIC202505 in Healthy Adult Volunteers
NCT07162441Dyslipidemia
Korea United Pharm. Inc.
Phase 1
50
Seoul
2025-08-12
Recruiting
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
NCT07099898Neoplasms, Lung
DrugsRis-Rez·Topotecan
GlaxoSmithKline
Phase 3
420
Changwon, Cheongju Chungcheongbuk-do, Daegu, Gyeonggi-do, Seongnam-si Gyeonggi-do, Seoul, Suwon Gyeonggi-do, Ulsan
2025-08-11
Recruiting
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
NCT07094516Alzheimer's Disease
DrugVHB937
Novartis Pharmaceuticals
Phase 2
407
Seoul, Incheon
2025-08-07
Recruiting
Binaural Sound During Phacoemulsification and Posterior Chamber Lens Implantation in Geriatric Patients
NCT07609186Cataract, Binaural Beats, Geriatric Anesthesia
Seoul National University Hospital
Not applicable
60
Seoul
2025-08-07
Recruiting
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
NCT07098338Non-Small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Datopotamab deruxtecan
AstraZeneca
Phase 2
278
Cheongju-si, Namdong-gu, Seongnam-si, Seoul, Suwon
2025-08-07
Active, closed
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
NCT07092865Respiratory Syncytial Virus Infections
GlaxoSmithKline
Phase 2
168
Seoul
2025-08-06
Recruiting
Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease
NCT07027072Mild Cognitive Impairment (MCI), Mild Dementia, Alzheimer's Disease
DrugKDS2010
NeuroBiogen Co., Ltd
Phase 2
114
Gwangju, Guri-si, Suwon, Incheon, Seoul
2025-08-06
Recruiting
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
NCT06952803Prostate Cancer
DrugsPrednisolone/Prednisone·Saruparib·Abiraterone
AstraZeneca
Phase 3
700
Busan, Daegu, Goyang-si, Seongnam-si, Seoul
2025-08-06
Recruiting
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
NCT07158918Solid Tumors
DrugsABL103·Keytruda·Pembrolizumab
ABL Bio, Inc.
Phase 1/2
65
Seongnam, Seoul
2025-08-06
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT07062965Breast Cancer
DrugsPF-07248144·Exemestane·Everolimus·Fulvestrant
Pfizer
Phase 3
400
Seongnam-si, Gangnam-gu, Seoul
2025-08-05
Recruiting
RestoratIon of Myocardial Function by PeRcutaneous cOronary interVEntion in Patients With Ischemic CardioMyoPathy
NCT06930092Ischemic Cardiomyopathy
Seoul National University Hospital
Not applicable
158
Seoul
2025-08-03
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
NCT07005102Non-Squamous Non-Small Cell Lung Cancer
DrugsTelisotuzumab Adizutecan·Osimertinib·Pemetrexed·Cisplatin
AbbVie
Phase 2/3
854
Busan, Cheongju-si, Seoul
2025-08-03
Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
NCT07044336Endometrial Cancer, Malignant Solid Tumour
DrugsAdriamycin·Taxol·Doxorubicin·Paclitaxel
AstraZeneca
Phase 3
800
Goyang-si, Gwangjin-gu, Seoul, Songpa-gu, Suwon
2025-08-01
Recruiting
Prospective CT Assessment After DCB
NCT07373145Coronary Artery Disease
Seoul National University Hospital
Observational
165
Seoul
2025-08-01
Not yet open
Thickness Map-Guided vs. Empirical PV Isolation Using Pulsed Field Ablation for Paroxysmal AF
NCT07068646Atrial Fibrillation
Yonsei University
Not applicable
298
Seoul
2025-08
Not yet open
A Study to Evaluate Safety and Efficacy of PBK_M2502
NCT07114406Intestinal Disease, Colonic Diseases, Gastrointestinal Disease, Digestive System Disease
Pharmbio Korea Co., Ltd.
Phase 3
110
Seoul
2025-08
Not yet open
Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice
NCT07068633Heart Valve Diseases, Aortic Valve Stenosis, Aortic Valve Insufficiency, Mitral Valve Insufficiency
Yonsei University
Observational
30,000
Seoul
2025-08
Recruiting
EOI Block for Laparoscopic Gastrostomy
NCT07119346Gastrostomy
Seoul National University Hospital
Not applicable
40
Seoul
2025-08
Active, closed
Evaluation of Safety, Tolerance, and Efficacy of Allogeneic LB-DTK-COV19 in Severe Coronavirus Disease 2019 Patients
NCT07709637COVID-19, COVID-19 (SARS-CoV-2 Infection)
LucasBio
Phase 1
1
Seoul
2025-07-31
Recruiting
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
NCT07094113KRAS Altered Advanced or Metastatic Solid Tumors
DrugsPanitumumab·Pembrolizumab
Amgen
Phase 1
434
Seoul
2025-07-31
Recruiting
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
NCT07096193Chronic Hepatitis Delta
Gilead Sciences
Phase 1/2
200
Ansan-si, Bucheon-si, Seoul
2025-07-31
Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
NCT06721013Immune Thrombocytopenia (ITP)
DrugPirtobrutinib
Eli Lilly and Company
Phase 1/2
68
Busan, Seoul
2025-07-30
Recruiting
First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord Injury
NCT06922890Spinal Cord Injury, Chronic Spinal Cord Injury
Yonsei University
Phase 1/2
9
Seoul
2025-07-30
Recruiting
Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
NCT06780111Esophageal Squamous Cell Carcinoma
DrugsIfinatamab Deruxtecan·Sacituzumab tirumotecan·Leucovorin·Adrucil
Merck Sharp & Dohme LLC
Phase 1/2
298
Goyang-si, Seoul
2025-07-30
Recruiting
Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients
NCT07009171Overweight, Obesity, Obese Patients
DrugKDS2010
NeuroBiogen Co., Ltd
Phase 2
75
Suwon, Seoul
2025-07-29
Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT07115043Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin), Renal Cell Carcinoma
DrugRilvegostomig
AstraZeneca
Phase 1/2
120
Seoul
2025-07-29
Recruiting
A Study of LY4175408 in Participants With Advanced Cancer
NCT07046923Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Endometrial Neoplasms, Neoplasm Metastasis
DrugsCisplatin·Carboplatin·Pembrolizumab
Eli Lilly and Company
Phase 1
240
Seoul
2025-07-28
Recruiting
A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).
NCT07005752Cholesterol Cholelithiasis
Myungmoon Pharma. Co. Ltd.
Phase 4
484
Ansan, Bucheon-si, Suwon, Busan, Daegu, Gyeonggi-do, Incheon, Seoul
2025-07-28
Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
NCT06858319Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases, Glomerulonephritis
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
220
Cheonan, Guri-si, Seongnam-si, Seoul
2025-07-28
Recruiting
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
NCT07071519Ulcerative Colitis
DrugRisankizumab
AbbVie
Phase 3
120
Yangsan, Seoul
2025-07-28
Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
NCT06911502Follicular Lymphoma
DrugsPrednisone/Prednisolone·Golcadomide·Bendamustine·Vincristine
Celgene
Phase 3
400
Seoul
2025-07-28
Active, closed
A Study to Investigate the Efficacy and Safety of Volrustomig ยฑ Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC
NCT07000149Advanced Clear Cell Renal Cell Carcinoma
DrugsCasdatifan·Volrustomig
AstraZeneca
Phase 1
9
Busan, Seoul
2025-07-28
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433Atherosclerotic Cardiovascular Disease, Overweight, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
12,800
Daegu, Goyang-si, Gyeonggi-do, Incheon, Seongnam-si, Gyeonggi-do, Seoul, Ulsan, Wonju-si, Gangwon-do
2025-07-25
Recruiting
FDG PET-CT in Advanced Breast Cancer
NCT07173868Histologically Confirmed Metastatic or Locally Advanced Breast Cancer With no Radical Topical Treatment Available, If There is Liver Metastasis, Which the Researcher Believes Will be Difficult to Evaluate the Response Accurately With Bone Metastasis or CT
Samsung Medical Center
Observational
100
Seoul
2025-07-25
Recruiting
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
NCT06757634Breast Cancer
DrugsGedatolisib·Ribociclib·Palbociclib·Letrozole
Celcuity Inc
Phase 3
1,180
Goyang, Incheon, Seongnam-si, Seoul, Suwon, Ulsan
2025-07-24
By invitation
Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia
NCT06743243General Anesthesia
DrugsFamotidine·Tegoprazan
Seok Kyeong Oh
Phase 4
174
Seoul
2025-07-23
Recruiting
Fluorescence Lymph Node Mapping for Colon Cancer Surgery
NCT07060443Right Hemicolectomy
Pusan National University Yangsan Hospital
Phase 2
186
Daegu, Daejeon, Goyang, Hwasun, Incheon, Jeonju, Seongnam, Seoul
2025-07-23
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
NCT06758401Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsSigvotatug vedotin·Pembrolizumab
Pfizer
Phase 3
714
Hwasun-gun, Seongnam, Suwon, Busan, Haeundae-gu, Seoul, Deagu
2025-07-23
Recruiting
A Study of OBIZUR in Adults With Acquired Hemophilia A (AHA) in South Korea
NCT06550882Acquired Hemophilia A
DrugsSusoctocog Alfa·Vaxzevria
Takeda
Observational
9
Seoul, Ulsan
2025-07-22
Recruiting
Application-Based Integrated Care in Patients After Pulse Field Ablation
NCT07119528Atrial Fibrillation Patients Treated With the FARAPULSEโ„ข PFA System
Yonsei University
Not applicable
500
Seoul
2025-07-21
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Seoul
2025-07-21
Recruiting
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
NCT07060807Breast Neoplasms
DrugsLiposomal doxorubicin·Patritumab deruxtecan·Xeloda·Abraxane
Merck Sharp & Dohme LLC
Phase 3
1,000
Seongnam, Gangnam-gu, Jongno-Gu, Seoul
2025-07-21
Recruiting
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)
NCT07049926Renal Cell Carcinoma
DrugsZanzalintinib·Belzutifan
Merck Sharp & Dohme LLC
Phase 1/2
140
Seoul
2025-07-20
Recruiting
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
NCT06824168Acute Myeloid Leukemia, Leukemia
DrugQuizartinib
Daiichi Sankyo
Phase 2
130
Busan, Daegu, Goyang-si, Incheon, Jeonju, Seongnam, Seoul, Suwon
2025-07-18
Rows per page Showing 601–700 of 2820
Previous 5 6 7 8 9 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 September 2026. https://priyalifescience.com/clinical-trials-south-korea/city/seoul?page=7

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,364 studies in total at the last sync on 26 Sep 2026, 19:49 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,820 of those studies with a site in Seoul.

How many clinical trials are recruiting in Seoul?

1,518 of the 2,820 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:49 UTC sync. A further 209 have not yet opened recruitment, 1,015 are active but closed to new participants, and 78 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.